Ex post facto management for KGSP-accredited firms eyed

Published: 2002-10-01 06:57:00

Updated: 2002-10-01 06:57:00

The Korea Food and Drug Administration (KFDA) announced it will implement its ex post facto management for KGSP-accredited firms next year in accordance with the basic pharmaceutical affairs inspection program, while it is focusing on the public campaign for the firm establishment of KGSP system ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK